Up to Date Coverage of the Ozempic Gallbladder Class Action Lawsuit Ozempic gallbladder class action lawsuit involves claims against the manufacturer, Novo Nordisk, for failing to adequately warn users about the risk of gallbladder issues, such as gallstones and acute gallbladder disease, associated with the drug
10.1016/j.cell.2018.02.017 Cell 191 ZucheroJ
Conclusion Integrating Ozempic into your diabetes management plan involves more than just taking the medication
[DOI] [PubMed] [Google Scholar] 38.Srensen K, Van Den Broucke S, Fullam J, et al
Among these, pioglitazone and liraglutide seem to improve some histological features of NASH but have no clear effect on fibrosis
any dosing changes must be agreed with the study team and must not be made independently